Is fOXP1 protein overexpression associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype , independent of gains and structural aberrations at 3p14.1?
FOXP1 is recurrently targeted by numeric, and rarely by structural, genetic aberrations in DLBCL. Only the presence of FOXP1 protein, irrespective of its gene status, is decisive for prognosis in DLBCL.
The above results indicate that rhEGF ointments can enhance burn wound healing significantly, and the ointment of 10 micrograms/g is a good choice for clinical application.